Kaleido Biosciences Inc. (KLDO)
NASDAQ · Healthcare
Kaleido Biosciences Inc. Shareholder Equity 2016–2021
Kaleido Biosciences Inc. annual shareholder equity history from 2016 to 2021. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Kaleido Biosciences Inc. shareholder equity as of December 31, 2021: 10.6M, a 48.25% decrease year-over-year.
- Kaleido Biosciences Inc. shareholder equity for 2021 were 10.6M, a 48.25% decrease from 2020.
- Kaleido Biosciences Inc. shareholder equity for 2020 were 20.5M, a 58.07% decrease from 2019.
- Kaleido Biosciences Inc. shareholder equity for 2019 were 48.9M, a 150.79% decrease from 2018.
- Kaleido Biosciences Inc. shareholder equity for 2018 were -96.2M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Kaleido Biosciences Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2021 | $11 |
| 2020 | $20 |
| 2019 | $49 |
| 2018 | $-96 |
| 2017 | $-44 |
| 2016 | $-17 |
Kaleido Biosciences Inc. Shareholder Equity — FAQ
Kaleido Biosciences Inc. (KLDO) shareholder equity over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see KLDO's shareholder equity history?
The chart and table above show Kaleido Biosciences Inc.'s shareholder equity by year and by quarter, including the growth rate.